abstract |
The present invention relates to imidazopyridine-2-carboxamide derivatives having the general formula (I) (Wherein X represents an optionally substituted phenyl group; R 1 represents a hydrogen atom, a halogen, a (C 1 -C 6 ) alkoxy group, a (C 1 -C 6 ) alkyl group, (C 3- C 7 ) represents a cycloalkyl (C 1 -C 6 ) alkyl group, (C 3 -C 7 ) cycloalkyl (C 1 -C 6 ) alkoxy group, amino or NRcRd group, wherein the alkyl and alkoxy groups are optionally substituted R 2 may be a hydrogen atom, an optionally substituted (C 1 -C 6 ) alkyl group, an optionally substituted (C 1 -C 6 ) alkoxy group, (C 3 -C 7 ) cyclo An alkyl (C 1 -C 6 ) alkyl group, a (C 3 -C 7 ) cycloalkyl (C 1 -C 6 ) alkoxy group, a (C 2 -C 6 ) alkenyl group, a (C 2 -C 6 ) alkynyl group, -CO —R 5 group, —CO—NR 6 R 7 group, —CO—O—R 8 group, —NR 9 —CO—R 10 group, —NR 11 R 12 group, halogen group, cyano group or optionally substituted R 3 represents a hydrogen atom, a (C 1 -C 6 ) alkyl group, a (C 1 -C 6 ) alkoxy group or a halogen atom; R 4 represents a hydrogen atom, (C 1 -C 4) alkyl group, a (C 1 -C 4) alkoxy group or a fluorine atom.). The invention also relates to its method of preparation and its use in therapy. |